The type III effector RipB from Ralstonia solanacearum RS1000 acts as a major avirulence factor in Nicotiana benthamiana and other Nicotiana species

por Nakano, Masahito, Mukaihara, Takafumi
Publicado 2019

Comprehensive Identification of PTI Suppressors in Type III Effector Repertoire Reveals that Ralstonia solanacearum Activates Jasmonate Signaling at Two Different Steps

por Nakano, Masahito, Mukaihara, Takafumi
Publicado 2019

Ralstonia solanacearum Type III Effector RipAY Is a Glutathione-Degrading Enzyme That Is Activated by Plant Cytosolic Thioredoxins and Suppresses Plant Immunity

por Mukaihara, Takafumi, Hatanaka, Tadashi, Nakano, Masahito, Oda, Kenji
Publicado 2016

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective

por Koga, Hironori, Iwamoto, Hideki, Suzuki, Hiroyuki, Shimose, Shigeo, Nakano, Masahito, Kawaguchi, Takumi
Publicado 2023

Suppression of DS1 Phosphatidic Acid Phosphatase Confirms Resistance to Ralstonia solanacearum in Nicotiana benthamiana

por Nakano, Masahito, Nishihara, Masahiro, Yoshioka, Hirofumi, Takahashi, Hirotaka, Sawasaki, Tatsuya, Ohnishi, Kouhei, Hikichi, Yasufumi, Kiba, Akinori
Publicado 2013

Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases

por KAWAGUCHI, TAKUMI, NAKANO, MASAHITO, SATANI, MANABU, SUMIE, SHUJI, YAMADA, SHINGO, AMANO, KEISUKE, KUROMATSU, RYOKO, SATA, MICHIO
Publicado 2014

Phosphatidylinositol-phospholipase C2 regulates pattern-triggered immunity in Nicotiana benthamiana

por Kiba, Akinori, Nakano, Masahito, Hosokawa, Miki, Galis, Ivan, Nakatani, Hiroko, Shinya, Tomonori, Ohnishi, Kouhei, Hikichi, Yasufumi
Publicado 2020

Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection

por Sumie, Shuji, Kawaguchi, Takumi, Kuromatsu, Ryoko, Takata, Akio, Nakano, Masahito, Satani, Manabu, Yamada, Shingo, Niizeki, Takashi, Torimura, Takuji, Sata, Michio
Publicado 2011

Primary Treatment with Molecular‐Targeted Agents for Hepatocellular Carcinoma: A Propensity Score‐matching Analysis

por Nakano, Masahito, Kuromatsu, Ryoko, Niizeki, Takashi, Okamura, Shusuke, Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Koga, Hironori, Torimura, Takuji
Publicado 2020

Association between contrast enhancement on contrast-enhanced CT and lenvatinib effectiveness in hepatocellular carcinoma

por Okamura, Shusuke, Shimose, Shigeo, Niizeki, Takashi, Kamachi, Naoki, Noda, Yu, Shirono, Tomotake, Iwamoto, Hideki, Nakano, Masahito, Kuromatsu, Ryoko, Koga, Hironori, Torimura, Takuji
Publicado 2022

Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast‐enhanced ultrasound

por Kamachi, Naoki, Nakano, Masahito, Okamura, Shusuke, Niizeki, Takashi, Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Noda, Yu, Kuromatsu, Ryoko, Koga, Hironori, Torimura, Takuji
Publicado 2021

Percutaneous Radiofrequency Ablation with or without Chemolipiodolization for Hepatocellular Carcinoma: A Propensity-Score-Matched Analysis

por Takaki, Kota, Nakano, Masahito, Fukumori, Kazuta, Yano, Yoichi, Zaizen, Yuki, Niizeki, Takashi, Kuwaki, Kotaro, Fukahori, Masaru, Sakaue, Takahiko, Yoshimura, Sohei, Nakazaki, Mika, Torimura, Takuji
Publicado 2022

Case Report: Exacerbation of varices following atezolizumab plus bevacizumab treatment of hepatocellular carcinoma: A case series and literature review

por Suzuki, Hiroyuki, Iwamoto, Hideki, Shimose, Shigeo, Niizeki, Takashi, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Yamaguchi, Taizo, Nakano, Masahito, Kuromatsu, Ryoko, Koga, Hironori, Kawaguchi, Takumi
Publicado 2022

Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching

por Shimose, Shigeo, Iwamoto, Hideki, Niizeki, Takashi, Tanaka, Masatoshi, Shirono, Tomotake, Moriyama, Etsuko, Noda, Yu, Nakano, Masahito, Suga, Hideya, Kuromatsu, Ryoko, Torimura, Takuji, Koga, Hironori, Kawaguchi, Takumi
Publicado 2023

Alternative treatments in advanced hepatocellular carcinoma patients with progressive disease after sorafenib treatment: a prospective multicenter cohort study

por Nakano, Masahito, Tanaka, Masatoshi, Kuromatsu, Ryoko, Nagamatsu, Hiroaki, Satani, Manabu, Niizeki, Takashi, Okamura, Shusuke, Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Noda, Yu, Koga, Hironori, Torimura, Takuji
Publicado 2016

Therapeutic Outcomes and Prognostic Factors of Unresectable Intrahepatic Cholangiocarcinoma: A Data Mining Analysis

por Shirono, Tomotake, Niizeki, Takashi, Iwamoto, Hideki, Shimose, Shigeo, Suzuki, Hiroyuki, Kawaguchi, Takumi, Kamachi, Naoki, Noda, Yu, Okamura, Shusuke, Nakano, Masahito, Kuromatu, Ryoko, Koga, Hironori, Torimura, Takuji
Publicado 2021

Clinical Importance of Regimens in Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Macrovascular Invasion

por Niizeki, Takashi, Iwamoto, Hideki, Shirono, Tomotake, Shimose, Shigeo, Nakano, Masahito, Okamura, Shusuke, Noda, Yu, Kamachi, Naoki, Hiroyuki, Suzuki, Sakai, Miwa, Kuromatsu, Ryoko, Koga, Hironori, Torimura, Takuji
Publicado 2021

Usefulness of a novel transarterial chemoinfusion plus external‐beam radiation therapy for advanced hepatocellular carcinoma with tumor thrombi in the inferior vena cava and right...

por Shirono, Tomotake, Koga, Hironori, Niizeki, Takashi, Nagamatsu, Hiroaki, Iwamoto, Hideki, Shimose, Shigeo, Nakano, Masahito, Okamura, Shusuke, Noda, Yu, Kamachi, Naoki, Kuromatsu, Ryoko, Ogo, Etsuyo, Torimura, Takuji
Publicado 2021

Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study

por Nakano, Masahito, Tanaka, Masatoshi, Kuromatsu, Ryoko, Nagamatsu, Hiroaki, Tajiri, Nobuyoshi, Satani, Manabu, Niizeki, Takashi, Aino, Hajime, Okamura, Shusuke, Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Koga, Hironori, Torimura, Takuji
Publicado 2015

Prevalence and profiles of ramucirumab-associated severe ascites in patients with hepatocellular carcinoma

por Kamachi, Naoki, Shimose, Shigeo, Hirota, Keisuke, Koya, Shunji, Iwamoto, Hideki, Niizeki, Takashi, Shirono, Tomotake, Nakano, Masahito, Hashida, Ryuki, Kawaguchi, Takumi, Matuse, Hiroo, Noguchi, Kazunori, Koga, Hironori, Torimura, Takuji
Publicado 2021